Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Branded Generic Formulations	1.41B	1.30B	-	914.79M
CDMO Products and Services	2.40B	326.00M	-	53.17M
Pharmaceuticals	-	-	1.54B	-
Total	3.81B	1.63B	1.54B	967.96M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
India	1.45B	1.37B	-	942.40M
International	2.36B	260.80M	-	-
Australia	-	-	-	16.92M
South Africa	-	-	-	4.85M
Others	-	-	-	3.79M
Total	3.81B	1.63B	-	967.96M